N@N

Brazil Ministry of Health Awards Zoll AED Contract for Public EMS System

^{Published on 2010-09-23 16:10:44 - Market Wire}
 

CHELMSFORD, Mass.--([ BUSINESS WIRE ])--ZOLL^® Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that the Ministry of Health in Brazil has awarded a contract to ZOLL to supply the [ AED Plus^® ]for a country-wide early defibrillation program.

"This is a major investment undertaken for a public EMS system on a worldwide scale. The AED Plus will be a key element to strengthen each link of the Chain of Survival and provide the best support when rescuing a victim of sudden cardiac arrest"

The contract for more than 5,000 units represents the largest single order placed with ZOLL for the ZOLL AED Plus since its introduction in 2002. It is also the largest purchase of AEDs by the Brazil Ministry of Health. The order standardizes the AED Plus in the SAMU (Sistema de Atendimento Movel de Urgencia (Emergency Mobile Treatment Service), Brazila™s public EMS Service, which includes ambulances, motorcycles, helicopters and rescue boats.

aThis is a major investment undertaken for a public EMS system on a worldwide scale. The AED Plus will be a key element to strengthen each link of the Chain of Survival and provide the best support when rescuing a victim of sudden cardiac arrest,a said Dr. Clesio Mello de Castro, Coordinator for the SAMU.

aThe expansive placement of the AED Plus across Brazil is an important initiative in improving survival rates from sudden cardiac arrest,a said Jonathan A. Rennert, President of ZOLL. aDelivering early defibrillation in combination with high-quality CPR is critical to improving resuscitation outcomes.a

The AED Plus requires minimal training to operate and is ideal for the infrequent rescuer. The AED Plus offers Real CPR Help^® to help rescuers provide high-quality manual CPR. This feedback technology features real-time audible and visual feedback to rescuers to help achieve the proper rate and depth of CPR chest compressions.

In addition to this initiative in early defibrillation, 40 units of the ZOLL [ AutoPulse^® ] non-invasive cardiac support pump was selected and implemented by SAMU Brasilia, one of the largest public EMS services in the country, earlier this year.

SAMU Brasilia installed AutoPulse units in its fleet of ambulances, one for each vehicle plus four spare training boards. The AutoPulse is the only automated chest compression device which uses a load-distributing LifeBand^® to squeeze the entire chest. As a result, victims receive more consistent, high-quality compressions than those delivered by simple automated CPR devices, which means improved blood flow. The AutoPulse was granted health clearance in January 2009 and is the only automated chest compression system available for sale in Brazil.

About Sudden Cardiac Arrest

SCA, an abrupt disruption of the hearta™s function, which causes a lack of blood flow to vital organs, claims more than 1 million lives each year. It is the leading cause of unexpected death in the world and strikes without warning. Currently, only about 5 percent of victims survive; 95 percent will die from SCA.

About ZOLL Medical Corporation

ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company in 2007, 2008, and 2009, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe. For more information, visit [ www.zoll.com ].

Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are aforward-lookinga statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled aRisk Factorsa in the Company'sQuarterlyReport on Form 10-Q filed with the SEC on August 11, 2010. You should not place undue reliance on the forward looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

Copyright © 2010 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL AED Plus, AutoPulse, LifeBand, and RealCPR Help are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.